Catalyst Biosciences, Inc.
26Patents
24Active
26Granted
50Portfolio score
Filing activity: Sep 30, 1999 → Feb 19, 2021 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7030231B1 | Membrane type serine protease 1 (MT-SP1) and uses thereof | Human Necessities | 57 | Expired |
| US9290757B2 | Protease screening methods and proteases identified thereby | Chemistry; Metallurgy | 24 | Active |
| US8211428B2 | Protease screening methods and proteases identified thereby | Chemistry; Metallurgy | 23 | Active |
| US7227009B2 | MT-SP1 polynucleotides and polypeptides | Human Necessities | 22 | Expired |
| US8383388B2 | Modified coagulation factor IX polypeptides and use thereof for treatment | Chemistry; Metallurgy | 21 | Active |
| US8778870B2 | Modified factor IX polypeptides and uses thereof | Human Necessities | 19 | Active |
| US8663633B2 | Protease screening methods and proteases identified thereby | Chemistry; Metallurgy | 16 | Active |
| US8519103B2 | Factor VII polypeptides that are modified and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US8445245B2 | Mutant MT-SP1 proteases with altered substrate specificity or activity | Chemistry; Metallurgy | 12 | Active |
| US7939304B2 | Mutant MT-SP1 proteases with altered substrate specificity or activity | Human Necessities | 11 | Active |
| US9795655B2 | Modified MT-SP1 proteases that inhibit complement activation | Chemistry; Metallurgy | 5 | Active |
| US9359598B2 | Mutant MT-SP1 proteases with altered substrate specificity or activity | Chemistry; Metallurgy | 5 | Active |
| US9328339B2 | Modified factor IX polypeptides and uses thereof | Human Necessities | 2 | Active |
| US10160961B2 | Factor VII polypeptides that are modified and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9476037B2 | Factor VII polypeptides that are modified and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11203749B2 | Factor VII polypeptides that are modified and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10258582B2 | Nicotinic receptor non-competitive antagonists | Chemistry; Metallurgy | 1 | Active |
| US9145552B2 | Modified factor X polypeptides and uses thereof | Human Necessities | 0 | Active |
| US10954501B2 | Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use | Human Necessities | 0 | Active |
| US11266724B2 | Modified factor VII polypeptides for subcutaneous administration and on-demand treatment | Chemistry; Metallurgy | 0 | Active |
| US9856467B2 | Modified factor X polypeptides and uses thereof | Human Necessities | 0 | Active |
| US10781435B2 | Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use | Human Necessities | 0 | Active |
| US10716770B2 | Nicotinic receptor non-competitive antagonists | Chemistry; Metallurgy | 0 | Active |
| US10982203B2 | Modified factor IX polypeptides and uses thereof | Human Necessities | 0 | Active |
| US11401513B2 | Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.